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ABSTRACT 
   
Hypoxia is a pathophysiological condition which results from lack of oxygen supply in 
tumors. The assessment of tumor hypoxia and its response to therapies can provide 
guidelines for optimization and personalization of therapeutic protocols for better 
treatment. Previous research has shown the difficulty in measuring hypoxia anatomically 
due to its heterogenous nature. This makes the study of hypoxia through various imaging 
modalities and mapping techniques crucial. The potential of hypoxia targeting T1 contrast 
agent GdDO3NI in generating hypoxia maps has been studied earlier. In this work, the 
similarities between hypoxia maps generated by MRI using GdDO3NI and pimonidazole 
based immunohistochemistry (IHC) in non-small cell lung carcinoma bearing mice have 
been studied. Six NCI-H1975 tumor-bearing mice were studied. All animal studies were 
approved by Arizona State University’s Institute of Animal Care and Use Committee 
(IACUC). Post co-injection of GdDO3NI and pimonidazole, T1 weighted 3D gradient echo 
MR images were acquired. For ex-vivo analysis of hypoxia, 30 μm thick tumor sections 
were obtained for each harvested tumor and were stained for pimonidazole and counter-
stained with DAPI for nuclear staining. Pimonidazole (PIMO) is clinically used as a “gold 
standard” hypoxia marker. The key process involved stacking and iterative registration 
based on quality metric SSIM (Structural Similarity) Index of DAPI stained images of 5 
consecutive tumor sections to produce a 3D volume stack of 150 μm thickness. Information 
from the 3D volume is combined to produce one final slide by averaging. The same 
registration transform was applied to stack the pimonidazole images which were previously 
thresholded to highlight hypoxic regions. The registered IHC stack was then co-registered 
with a single thresholded T1 weighted gradient echo MRI slice of the same location (~156 
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μm thick) using an elastic B-splines transform. The same transform was applied to achieve 
the co-registration of pimonidazole and MR percentage enhancement image. Image 
similarity index after the co-registration was found to be greater than 0.5 for 5 of the 
animals suggesting good correlation. R2 values were calculated for both hypoxic regions 
as well as tumor boundaries. All the tumors showed a high boundary correlation value of 
R2 greater than 0.8. Half of the animals showed high R2 values greater than 0.5 for hypoxic 
fractions. The RMSE values for the co-registration of all the animals were found to be low 
further suggesting better correspondence and validating the MR based hypoxia imaging. 
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CHAPTER 1 
INTRODUCTION 
1.1 CANCER AND SIGNIFICANCE OF TUMOR HYPOXIA 
Cancer is a deadly disease in which a group of abnormal cells divide and multiply 
uncontrollably. Metastatic cancerous growth has the potential to spread and invade to 
various parts of the body. Cancer disrupts lifestyles and results in death often. Various 
research and surveys have shown that by 2015 almost 90.5 million people were affected 
by over 100 different types of cancer [1]. Most of the malignant cancers excepting 
leukemia form solid tumors. In solid tumors, hypoxia is a condition resulting from lack 
of oxygen supply due to rapid consumption of oxygen by proliferating cancer cells. 
Due to excessive cell density, diffusion distance between oxygen rich blood vessels 
and cells increases and transport capacity of blood reduces due to presence of disease 
related anemia [2]. Hypoxia decreases the efficiency of radiotherapy and anticancer 
chemotherapy. Tumors have a median partial pressure of oxygen at around 10 mmHg 
as opposed to normal tissue which have oxygen partial pressures in the range of 40-60 
mmHg. Hypoxic cells become resistant to radiotherapy through HIF-1 (Hypoxia 
Inducible Factor 1) mediated mechanisms. Studies show that higher levels of oxygen 
promote the damage caused by radiotherapy owing to the fact that oxygen combines 
with the free radical produced by ionization [3][4]. Due to larger diffusion distances 
and lower diffusion rates it gets more difficult for chemotherapy drugs to reach hypoxic 
cells [5]. Chemotherapy studies have shown that hypoxia leads to the upregulation of 
drug resistant genes like p-glycoprotein [6] and the decrease in oxygen level reduces 
the cytotoxic DNA lesions caused in tumorous cells [4]. 
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Figure 1 Graph showing results from an experiment done by J. Martin Brown et. Al 
to see the response to radiation therapy in different levels of oxygen saturation [4]. 
This makes study and imaging of hypoxia extremely important. Localization of 
hypoxia helps in targeted therapies for example delivering hypoxia-selective 
cytotoxins/drugs, and HIF-1 inhibitors and booster radiation dose to hypoxia specific 
regions of the tumor in a therapy called SIB-IMRT (simultaneous integrated boost 
intensity-modulated radiation therapy) [3]. 
1.2 CURRENT HYPOXIA IMAGING TECHNIQUES 
Some of the direct techniques used to image hypoxia include invasive injection of 
oxygen probes, phosphorescence quenching and 19F magnetic resonance spectroscopy. 
These techniques are invasive and/or have limited depth of view in imaging hypoxia. 
To overcome this many efficient in vivo methods of imaging have been developed like 
use of endogenous markers like glucose transporter 1, HIF 1 and Osteopontin [7].  
Physiological methods like BOLD MRI, photoacoustic tomography, near-infrared 
spectroscopy, immunohistology and PET imaging have also been studied to detect and 
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image hypoxia. MR contrast agents like [18F]fluoromisonidazole, 
[18F]fluoroerythronitroimidazole, copper-64 diacetyl-bis(N4 -
methylthiosemicarbazone), etc. used for imaging hypoxia exploits the principle of 
selective enzyme-mediated reduction of the nitro group in 2-nitroimidazole-containing 
compounds under hypoxic conditions [8][9]. The hypoxia targeting ability of a 
gadolinium tetraazacyclododecanetetraacetic acid monoamide conjugate of 2-
nitroimidazole (GdDO3NI) has been validated previously in-vitro using 9L glioma 
cells incubated under hypoxia and AT1 xenograft models respectively [10]. Ex vivo 
methods of assessing tumor hypoxia include immunohistochemical staining for either 
intrinsic markers of hypoxia or externally injected nitroimidazoles adducts. 
Pimonidazole targets hypoxic cells by binding to thiol-containing proteins and gets 
detected by using a mouse monoclonal antibody [11]. Pimonidazole is currently the 
‘gold standard’ for measuring hypoxia ex vivo. Both electrode and 
immunohistochemical assessments are invasive. In immunohistological staining, 
unless whole-tumor mounts are used, tumors need to be harvested and sectioned and 
will provide a limited sample and have cutting and distortion artifacts due to sectioning. 
Hence, combination study of two different modalities of imaging can give interesting 
results. 
1.3 PREVIOUS WORK  
GdDO3NI has great potentials for non-invasive longitudinal study and imaging of 
hypoxia. Previously in ProBE Lab, GdDO3NI has been used to generate three-
dimensional maps to study degree and distribution of hypoxia before and after 
administration of hypoxia activated therapy. Six different NCI-H1975 tumor-bearing 
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mice were studied. All animal studies were approved by Arizona State University’s 
Institute of Animal Care and Use Committee (IACUC) and were performed in 
accordance with the relevant guidelines. The mice were co-injected with 0.3 mmole\kg 
body weight GdDO3NI and 60 mg/kg pimonidazole. The tumors were ready for 
imaging when they reached ~300 mm3 in volume. T1 weighted 3D gradient echo MR 
images with an isotropic resolution of ~156 μm, a TE of 3 ms, TR of 80 ms and an 
alpha of 35º (FOV= 2 cm × 2 cm × 2 cm, matrix=128 × 64 × 64 reconstructed to 128 x 
128 x 128) were acquired for in-vivo analysis. One 3D gradient echo image was 
acquired pre-injection and two 3D gradient echo images were acquired at 60 min and 
125 min post-GdDO3NI injection. For ex-vivo analysis of hypoxia, 30 μm thick tumor 
sections (30 sections) at the same imaging plane as MR were obtained using a cryostat. 
The tumor sections were stained with FITC conjugated anti-pimonidazole antibody and 
counterstained with DAPI (4′,6-diamidino-2-phenylindole) for nuclear staining. The 
stained sections were mounted with Vectashield medium (Vector Laboratories, 
Burlingame, CA) and visualized under the DMI 6000B Leica Microsystems 
microscope using the green channel for pimonidazole and the blue channel for DAPI 
at 5X magnification. Pimonidazole is clinically used as a “gold standard” hypoxia 
marker and is ideal for comparison. GdDO3NI successfully reported the baseline 
distribution and intensity of hypoxia in non-small cell lung cancer models (NCI-
H1975). A response to the hypoxia activated prodrug tirapazamine (TPZ) was also 
studied. Heterogeneous distribution of hypoxia was found within all the NSCLC 
tumors. A significant decrease in tumor growth as compared to the untreated control 
was observed in TPZ treated tumors. Various other studies have shown that effective 
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TPZ treatment results in vascular shutdown in tumors, resulting in increased hypoxia 
in the central regions of the tumors [12][13]. 
 
 
 
 
 
 
 
 
Figure 2 Description of imaging protocol used previously [14]. 
1.4  IMAGE REGISTRATION 
Conventional in vivo diagnostic imaging techniques have been helpful for the detection 
of hypoxia in tumor, but with advancement of different techniques to increase the 
sensitivity and specificity of tumor information provided, the need to combine 
information provided by different modalities is paving a path towards in vivo imaging 
without the need for invasive techniques. Image registration is a technique to compare 
information visible on multiple images. It aligns multiple images into one scene to 
produce a final fused image representing information from all the input images. 
Histology staining techniques show the ground truth information and can be used to 
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compare with the spatial distribution represented by MR images. Figure 3 show an 
example of registration used on DCE MRI for abdominal tumors [15]. Previously, 
research has been done for better detection of prostate tumor by multi-modality 
registration of histology with ultrasound and MRI [16][17].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Very few studies have been done to study hypoxia through multi-modality registration.  
Comparing spatial correspondence between MRI and histology provides information 
about MRI’s capability to characterize hypoxia in tumor and underlying 
pathophysiology. Comparison with histology is particularly challenging because of 
Figure 3 An example of registration methodology used by David Pilutti  
et al. to apply to DCE MRI. (a) is the fixed image (b) is the moving image (c) 
is the registered image (d) is the ROI mask and (e) and (f) show checkerboard 
view of (a) and (b) before and after registration. 
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deformations that happen through the process. For final histological sections the tumor 
tissue is excised, fixed by formalin and dehydrated followed by embedding in paraffin, 
sectioning, and rehydration to get staining. This causes significant tissue deformation 
which also changes tumor appearance. Difference in slice thickness in different 
modalities and motion artifacts also pose additional challenges. There are inherent 
differences in intensity patterns generated as histology is in color and MRI is grayscale. 
Although rigid body registration and affine registration are good in aligning shape and 
structure of tumors they cannot account for non-linear deformation and stretching in 
internal patterns. To overcome this elastic registration techniques, must be used for co-
registration. Research has been done to automate multi-modality registration to remove 
the errors that arise during landmark based registration. Extensive research has been 
done for multi-modality registration of brain imaged through different in vivo imaging 
modalities like CT, PET, fMRI, SPECT, etc. [18][19][20]. But most automated 
registrations are between two in vivo modalities which do not have to deal with 
deformation caused to the image in ex vivo images. Comparing histology to MRI is still 
landmark based and done with manual visual decision making. Peter J. Hoskin et al. 
have studied the comparison between pimonidazole histology and BOLD MRI [21] and 
Stephanie B. Donaldson et al. have studied comparison of DCE MRI with 
pimonidazole histology [22]. Lejla Alic et al. have studied the registration of MRI and 
histology in tumors grown in rats. They have observed a decrease in tumor volume 
calculated from both the modalities after registration. This shows there is significant 
deformation in histology sectioning[23]. Maryana Alegro et al. have registered whole 
brain MRI images to histology [24].  
8 
 
 
This stresses on the need to study comparison between different modalities imaging 
hypoxia for a comprehensive and inclusive study. This research will investigate the 
ability of MRI agent GdDO3NI to depict clinically significant tumor hypoxia and show 
its efficacy in comparison to pimonidazole stained images. Establishing good 
correspondence in hypoxia intensity patterns after multi-modality registration of 
stacked histology and MRI should validate the use of GdDO3NI to study hypoxia. In 
vivo MRI based hypoxia imaging will become as significant as pimonidazole imaging 
which represents ground truth and hence eliminate the need for biopsy and staining for 
further studies. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 INTER MODALITY REGISTRATION OF HISTOLOGY SECTIONS  
DAPI is a fluorescent stain that binds strongly to adenine–thymine rich regions in DNA 
and hence DAPI images are used to delineate tumor tissue for analysis. The process of 
producing a final histology volume involved stacking and registration of DAPI stained 
images of 5 consecutive tumor sections, each of 30 μm thickness, obtained from 
fluorescence microscopy to produce a 3D stack of 150 μm thickness. The stack 
corresponds to a single T1 weighted gradient echo image of about 156 μm thickness. 
This was done through the iterative registration of the 5 consecutive DAPI images based 
on a quality metric like SSIM (Structural Similarity) Index. 
The following procedures describe pre-processing done before registration of histology 
sections. 
2.1.1 ROI Selection and Sampling 
In intensity-based image registration it is essential to select out the region of interest 
in the image. The slide containing the tumor and any particles outside show up as 
different intensities in the histology image and have been carefully cropped out 
manually. For the next steps in the computational pipeline it was necessary to 
downsample the dataset to avoid running out of memory. Empirically a downsizing 
factor of 5 was found to give optimum registration time utilizing the 8GB RAM 
available. Hence all the input DAPI and PIMO images were resized accordingly. 
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Figure 4 ROI selection to remove background noise 
2.1.2 Histogram Equalization: 
Histogram equalization is a contrast enhancement technique in image processing. 
Intensities in a series of images are better distributed after this adjustment. During 
acquisition of histology images, variation in lighting and unavoidable variations in 
staining intensity can cause intensity inconsistencies among the sections. This may 
cause one image to look brighter than another which in turn will give uneven 
registration results. This is fixed through a process called histogram equalization 
by use of a suitable MATLAB code. The code considers the histogram of the first 
image in the DAPI and PIMO stack as a global reference and matches the histogram 
ranges of the rest of the images to this reference. 
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Figure 5 The first row shows a set of input images having intensity variations. The 
second row shows the same set after histogram equalization. The input image set 
now has consistent intensity range. 
2.1.3 Thresholding of PIMO Images and PIMO Hypoxic Fraction 
Thresholding is an effective segmentation technique to separate an image into a 
foreground and a background. The foreground shows information of interest and in 
this case highlights hypoxic regions. Hypoxic regions in PIMO images appear 
brighter (have higher intensity values) than normal non-hypoxic regions. A 
threshold value for hypoxic region is found by manually selecting 3 ROIs in normal 
regions and averaging the highest intensities found within each of these 3 regions. 
The thresholding is defined by the following equation: 
𝐼(𝑥, 𝑦) = {
𝑓(𝑥, 𝑦), 𝑓(𝑥, 𝑦) > 𝑇
0, 𝑓(𝑥, 𝑦) ≤ 𝑇
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Where, T is the calculated threshold value, I(x,y) is the final thresholded image and 
f(x,y) is the intensity value of the pixel at coordinate (x,y). A threshold is found this 
way for each individual PIMO image. The average of these is considered as 
threshold used to calculate the PIMO hypoxic fraction of the stacked image. All 
pixel values above this threshold are considered hypoxic. The count is divided by 
the total number of pixels in the delineated tumor area to give the hypoxic fraction. 
 
 
 
 
 
Figure 6 Input DAPI image before (a) and after (b) thresholding. 
Description of MATLAB program for registration for each individual tumor: 
The program reads the 5 input DAPI and 5 input PIMO images serially and stores to 
two separate stacks. The first DAPI image is stored as the fixed image and the second 
DAPI image is stored as the moving image. The moving image is then registered to the 
fixed image through the generation of a transform matrix using inbuilt functions 
imregister and imwarp. The transform is based on intensity difference and does rigid 
body translation and rotation. Both the fixed and moving images are referenced to fit a 
global reference frame based on intensity considering the pixel extent and image extent. 
Then the degree of translation and rotation in the global reference frame is found.  After 
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the moving DAPI is registered to the fixed DAPI, the same registration transform is used 
to on the corresponding PIMO images. The two registered DAPI obtained from this 
process are stacked and averaged to obtain a final DAPI for comparison with the next 
DAPI. Next the registered DAPI from the previous step is stored as fixed image for the 
next registration step and the third DAPI from the original stack is stored as moving 
image. Registration is done again in the way described above. This loop continues till 
all the DAPI images are registered and all the corresponding PIMO images are 
registered. The resulting images are stacked and averaged for a final registered DAPI 
and PIMO image to represent all the 5 input images.  
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Figure 7  Representation of working algorithm for intra-modality registration. (1) is the 
first fixed image and (2) is the first moving image. 
2.2 MULTI MODALITY IMAGE REGISTRATION 
The registered IHC stack image was co-registered with a single T1 weighted gradient 
echo MRI slice of the same location (~156 μm thickness). This was performed through 
manual selection of corresponding boundary landmarks on DAPI stained image and MR 
image which generated an elastic B-splines transform. The resulting transform was 
applied to achieve the co-registration of pimonidazole and MR percentage enhancement 
image. The registration processes were done separately for each individual animal in 
MATLAB.  
2.2.1 Pre-Processing before Co-Registration. 
2.2.1.1 MR Percentage Enhancement and Segmentation 
The 3D gradient echo MR images obtained pre-GdDO3NI injection and 125 min 
post-injection are used to find a MR percentage enhancement image through a pre-
developed MATLAB code. The pre-injection MR image is subtracted from MR 
image at 125 min post-injection. The result is divided by pre-injection image to 
remove baseline effect. One slice of the MR enhancement image is selected by 
visually comparing with the registered PIMO image. In-vivo MR images give a 
scanned image of the tumor along with the whole body of the mouse. After selection 
of the MR percentage enhancement slice, the corresponding T1 weighted gradient 
echo MR image obtained 60 min post-injection is segmented manually to select 
tumor region useful for comparison by the creation of a mask in MATLAB. This 
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involves careful selection of boundary to distinguish tumor from surrounding fat 
and muscle regions. The mask is then applied to corresponding MR percentage 
enhancement image. 
 
 
 
 
 
Figure 8 Input T1 weighted gradient echo MR image (b) after segmentation is done 
to keep tumor region of interest. 
2.2.1.2 Thresholding and MR Hypoxic Fraction 
Thresholding is done on the selected MR percentage enhancement image used for 
comparison with PIMO image. Hypoxic regions in MR percentage enhancement 
image appear brighter (have higher intensity values) than normal non-hypoxic 
regions. According to studies previously conducted in the lab [14], a threshold 
value of 10 percent over baseline is considered. This threshold is used to calculate 
the MR hypoxic fraction. All pixel values above this threshold are considered 
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hypoxic. The count is divided by the total number of pixels in the delineated tumor 
area to give the hypoxic fraction. 
 
 
Figure 9 Input MR percentage enhancement image before (a) and after (b) 
thresholding. 
2.2.1.3 Motion Correction 
Motion artifact was detected between MR image acquired at 125 min post-
gdDO3NI injection and MR image acquired before injection. This motion artifact 
can give rise to error in the MR percentage enhancement image which uses a 
subtraction of the two MR images. Since the motion occurs in 3 dimensions, the 
artifact is removed by 3D rigid body registration of the two gradient echo images 
using MATLAB code. The code references both the images according to a global 
frame of reference and matches the two images based on intensity difference to 
align both the images. Figure 11 depicts motion correction through checkerboard 
view. To show motion in 3D the xy, yz and zx planes are pictured individually 
which represent motion in z, x and y directions respectively. Boundary mismatch 
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(indicated by red arrow) in Figure 10 (a) is fixed in (b) after registration. Similarly, 
in Figure 11 the red arrows show changes in alignment after motion correction. 
 
 
 
 
 
Figure 10   Overlay images of MR images at first and last time point of 
acquisition before (a) and after (b) motion correction for axial view orientation. 
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Figure 11 Checkerboard display of MR images of one tumor before (left-hand side image) 
and after (right-hand side image) motion correction shown in 3 directions to represent 3D 
motion. 
2.2.2 Boundary Landmark Selection for Registration 
A landmark in an image is a cognitive marker or reference point. Typically, image 
registration based on boundary landmarks focuses on matching the shapes in the 
two images. Boundary landmarks include sharp curves and edges in the over-all 
shape. To register PIMO to MR a careful selection of 6-10 corresponding points is 
done on each tumor. This can be seen Figure 12 as corresponding pairs of red and 
yellow dots on MR ROI image and DAPI ROI image. This is further used to 
generate transformation matrix for the co-registration.  
 
 
 
 
 
Figure 12 Landmark selection on MR ROI and DAPI ROI for correspondence 
Description of MATLAB program for registration: 
   A MATLAB code developed previously in ProBE lab is used for the co-registration 
process. It uses MR percentage enhancement image to compare the intensity pattern 
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with input PIMO image. Corresponding T1 weighted gradient echo image at 60 min 
post-GdDO3NI injection and registered DAPI image are used as input to align the 
tumors for best co-registration results. Inbuilt function point_registration is used to 
create a 2D b-spline grid, which transforms the global space fit a set of points from 
moving image to a set of points on the fixed image. The function bspline_transform 
registers the two images based on the generated transform. This function is based on the 
algorithm written by D. Rueckert et al. [25].  
 
 
 
 
 
Figure 13 Yellow lines on (a) represent transformation followed after landmark selection 
to obtain a final registered PIMO image in (b).  
2.2.3 Structural Similarity (SSIM) Index 
MATLAB code is used to calculate the SSIM Index after co-registration. The SSIM is 
a qualitative statistic showing the similarity between two images. This index was first 
developed by Zhou Wang et al. [26]. It is based on the combination of three different 
measure: luminance comparison l(x,y), contrast comparison c(x,y) and structural 
comparison s(x,y). Luminance is estimated as the mean intensity, signal contrast is 
estimated by standard deviation and structural comparison is obtained after the signals 
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are normalized by their own standard deviations so that both signals have unit standard 
deviations. These comparisons are calculated locally from various windows on both the 
images measuring N*N size and is governed by the following final equation [26].  
𝑆𝑆𝐼𝑀(𝑥, 𝑦) =
(2𝜇𝑥𝜇𝑦 + 𝑐1)(2𝜎𝑥𝑦 + 𝑐2)
(𝜇𝑥2 + 𝜇𝑦2 + 𝑐1)(𝜎𝑥2 + 𝜎𝑦2 + 𝑐2)
 
Where, x and y are the two input images, 𝜇𝑥, 𝜇𝑦 are the means of y, 𝜎𝑥
2, 𝜎𝑦
2 are the 
variance of x and y, 𝜎𝑥𝑦 is the covariance of x and y, c1 and c2 are constants based on 
the dynamic range of pixel-values of the two images. This index lets us study the 
similarity in hypoxia intensity distribution depicted by both the imaging modalities.  
2.2.4 Selection of Final MR Image Slice and Registered PIMO Image 
One MR image thickness corresponds to combination of 5 consecutive histology 
sections. This requires a careful selection of MR image and input PIMO images to obtain 
the closest matching section and have proper registration. To achieve this, I have started 
by selecting an MR center slice and find various combinations of consecutive PIMO 
stacks. The MR center slice may also be changed to best match histology stack. Each 
PIMO stack is registered and co-registered with MRI to obtain similarity index value 
which indicates correspondence. The best corresponding result is kept for further 
analysis.  
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Figure 14 The first figure shows a selected a selected MR slice for one tumor and (1) 
and (2) show two different PIMO registered and stacked images to compare with MRI.  
2.2.5 Coefficient of Determination and Root Mean Square Error 
Coefficients of determination (R2) is found for every tumor. One represents overall 
tumor hypoxia correlation and the other represents boundary R2 to show correspondence 
of boundaries after co-registration. Hypoxic R2 values are obtained from correlation 
between registered PIMO image and MR percentage image. For boundary R2 value, 
boundaries are traced on binary masks of the final registered images using inbuilt 
MATLAB function bwtraceboundary. Correlation value is calculated from the obtained 
boundaries. Greater R2 values represent better registration. 
2.2.6 Statistical Analysis 
The hypoxic fractions calculated from the MR image and the PIMO image were 
plotted using RStudio software. Linear regression line was plotted to view correlation. 
A 95% confidence interval area was plotted over the regression line to look for the 
possibility of outliers. 
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CHAPTER 3 
RESULTS 
Multiple co-registrations were done to find the matching center slices in both MR and 
histology set. This involved the combination of different sets of 5 consecutive histology 
sections to best align with a selection MR image. After the best images for comparison 
were determined the transform for correspondence is calculated based on manually 
selected landmarks, there. To minimize inconsistency due to human error, the co-
registration process using the selected images was done multiple times and the best 
result with maximum visual alignment and SSIM index was selected for further hypoxia 
analysis. 
3.1 Hypoxic Fraction Analysis 
The hypoxic fractions obtained after registration were studied through correlation 
analysis with respect to PIMO hypoxic fraction. For half of the tumors hypoxic fractions 
represented by both modalities are similar. This means there is greater similarity in 
hypoxia imaged by the two different modalities. For one tumor, the MR hypoxic fraction 
and PIMO hypoxic fraction are widely different. This is an outlier in Figure 15 
representing the scatter plot with regression line.  
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Table 1 Comparison of hypoxic fractions post registration 
A 95% confidence interval range is also plotted along with the regression line. The 
outlier is seen to be outside the confidence interval range. The R2 value obtained is 
0.237. Since, one data point lies outside confidence interval, it was removed from the 
dataset and correlation study was done again. As seen in Figure, after exclusion of 
outlier the remaining 5 tumors lie within 95% confidence interval range. The R2 value 
obtained is 0.486 showing a great increase with respect to original correlation study. 
 
 
 
 
 
 
 
 
Figure 15 Scatter plot for hypoxia fractions for all 6 tumors. X axis represents PIMO 
hypoxic fraction and Y axis represents MR hypoxic fraction. Shaded area represents 95% 
confidence interval range. 
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Figure 16 Scatter plot for hypoxia fractions for all 5 tumors (excluding oulier). X axis 
represents PIMO hypoxic fraction and Y axis represents MR hypoxic fraction. Shaded area 
represents 95% confidence interval range. 
3.2 Comparison of Registration Metrics 
Image similarity index after the co-registration was found to be greater than 0.5 for 5 of 
the animals suggesting good correlation. R2 values were calculated for tumor 
boundaries. All the tumors showed a high boundary correlation value of R2 greater than 
0.8. This is an indicator of proper selection of landmarks for registration and higher 
accuracy of registration transform.  
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Table 2  Comparison of metrics obtained from the multi-modality registration process 
for the six tumor-bearing animals. 
A similar trend between calculated boundary R2 and similarity index can be observed. 
The tumor corresponding to highest R2 has highest SSIM and vice-versa.  
3.3 Visualization of Intra Modality Registration 
The registered and stacked histology sections are visualized using a 3D volume viewer 
in ImageJ to check boundary outline of registered stack. If boundary continuation looks 
inconsistent then the registration process is repeated with modification to registration 
optimizer and iteration parameters. This is done we see consistent boundary outline and 
a definitive consistency in internal structure intensity. 
 
Figure 17 Intra-modality registration results. (a) Registered DAPI stained image stack 
and (b) Registered pimonidazole image stack for the first animal. 3D visualization of 
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registered DAPI stack shown in grayscale in (c) shows consistent boundary outline 
between the histology sections. 
 3.4 Visualization of Inter Modality Registration 
The co-registration is studied visually to check for alignment. Alignment and boundary 
correspondence is also verified with the help of checkerboard display. Checkerboard 
display overlays the two images and make comparison of internal intensity patterns 
easy.  
 
Figure 18  Representation of inter-modality registration of MR and Histology for the six 
tumors. First column shows thresholded MR percentage enhancement image and second 
column shows pimonidazole image generated after co-registration. 
27 
 
To show efficiency of co-registration the input ROI boundaries and the final boundary 
obtained after co-registration are plotted on the final registered PIMO image. In each 
case the green boundary represents ROI of input MR image, the red boundary represents 
ROI of input DAPI and the yellow boundary represents ROI of final registered image.  
From Figure 19 it can be seen all the tumors there is high boundary correspondence after 
registration. 
 
 
Figure 19 Left-hand image shows checkerboard view after co-registration for 
the six tumors. Right-hand image in each case shows ROI boundaries on the 
final registered PIMO image. 
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In three of the cases a strong correspondence can be seen visually in the internal 
distribution of hypoxia. For a few tumors internal intensity correspondence is low and 
should be further investigated. The RMSE values for the co-registration of all the 
animals were found to be low further suggesting better correspondence and more 
accuracy.  
 
CONCLUSION 
Non-rigid registration is essential in the process of registering histology sections. 
Matching of histological PIMO stained sections to MR images of tumors is facilitated 
by using a multi-step registration process. The six tumors were successfully co-
registered and hypoxia patterns were studied. All the tumors show good boundary 
correlation, however, there is mismatch in internal patterns in two of the tumors. This 
may be due to distortion caused by sectioning and staining. Good boundary correlation 
and high correlation value for PIMO hypoxic fraction and MR hypoxic fraction indicate 
a high similarity in hypoxia imaging by pimonidazole and MR agent GdDO3NI. This is 
further supported by similarity index calculation which is high for 5 of the tumors. Thus, 
validating GdDO3NI based MRI as a convenient in vivo hypoxia imaging method. This 
will help future studies in saving time and resources by not having to do histology and 
will make detection and diagnosis based on hypoxia faster. 
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FUTURE WORK 
For a highly accurate co-registration with good correspondence in internal intensities, a 
more extensive study is needed. In this regard, there are several possible procedures 
which could be implemented to further increase the robustness and accuracy of the 
technique within a reasonable processing time. For example, using the full color range 
of the histology images could help automatic segmentation. Acquiring images with a 
stereotactic marker system12 could facilitate the rigid registration of images. This has 
been seen to speed up the registrations and make manual annotations easier [27]. The 
use of contrast agent to alter the tumor structural detail and highlight different 
orientation should be considered as well. Though not extremely promising due to 
variations arising from sectioning artifacts, completely automated co-registration 
instead of manual landmark selection should be considered too. 
 
 
 
 
 
 
 
 
 
 
 
30 
 
REFERENCES 
[1] G. 2015 D. and I. I. and P. GBD 2015 Disease and Injury Incidence and Prevalence 
Collaborators, “Global, regional, and national incidence, prevalence, and years lived 
with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for 
the Global Burden of Disease Study 2015.,” Lancet (London, England), vol. 388, 
no. 10053, pp. 1545–1602, 2016. 
[2] P. Vaupel and L. Harrison, “Tumor hypoxia: causative factors, compensatory 
mechanisms, and cellular response.,” Oncologist, vol. 9 Suppl 5, no. suppl 5, pp. 
4–9, 2004. 
[3] H. HARADA, “How Can We Overcome Tumor Hypoxia in Radiation Therapy?,” 
J. Radiat. Res., vol. 52, no. 5, pp. 545–556, 2011. 
[4] J. M. Brown, “Tumor Hypoxia in Cancer Therapy,” Methods Enzymol., vol. 435, 
pp. 295–321, Jan. 2007. 
[5] R. E. Durand, “The influence of microenvironmental factors during cancer 
therapy,” In Vivo (Brooklyn)., vol. 8, no. 5, pp. 691–702, 1994. 
[6] K. M. Comerford, T. J. Wallace, J. Karhausen, N. A. Louis, M. C. Montalto, and 
S. P. Colgan, “Hypoxia-inducible factor-1-dependent regulation of the multidrug 
resistance (MDR1) gene,” Cancer Res., vol. 62, no. 12, pp. 3387–3394, 2002. 
[7] P. Vaupel and A. Mayer, “The Clinical Importance of Assessing Tumor Hypoxia: 
Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities,” 
Antioxid. Redox Signal., vol. 22, no. 10, pp. 878–880, 2015. 
[8] J. M. Brown, “Selective Radiosensitization of the Hypoxic Cells of Mouse Tumors 
with the Nitroimidazoles Metronidazole and Ro 7-0582,” Radiat. Res., vol. 64, no. 
3, pp. 633–647, 1975. 
[9] W. J. G. Oyen, J. H. A. M. Kaanders, and J. Bussink, “Molecular imaging of 
hypoxia,” Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 57, 
no. 3, pp. 217–218, 2013. 
[10] P. K. Gulaka, F. Rojas-Quijano, Z. Kovacs, R. P. Mason, A. D. Sherry, and V. D. 
31 
 
Kodibagkar, “GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for 
imaging tumor hypoxia in vivo,” J Biol Inorg Chem, vol. 19, no. 2, pp. 271–279, 
2014. 
[11] M. A. Varia et al., “Pimonidazole: A novel hypoxia marker for complementary 
study of tumor hypoxia and cell proliferation in cervical carcinoma,” Gynecol. 
Oncol., vol. 71, no. 2, pp. 270–277, 1998. 
[12] L. A. Huxham, A. H. Kyle, J. H. E. Baker, K. L. McNicol, and A. I. Minchinton, 
“Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts,” 
Radiother. Oncol., vol. 78, no. 2, pp. 138–145, 2006. 
[13] L. J. Bains, J. H. E. Baker, A. H. Kyle, A. I. Minchinton, and S. A. Reinsberg, 
“Detecting Vascular-Targeting Effects of the Hypoxic Cytotoxin Tirapazamine in 
Tumor Xenografts Using Magnetic Resonance Imaging,” Int. J. Radiat. Oncol. 
Biol. Phys., vol. 74, no. 3, pp. 957–965, 2009. 
[14] S. Agarwal, R. Vidya Shankar, L. J. Inge, J. Smaill, A. V Patterson, and V. 
Kodibagkar, “Mri assessment of changes in tumor oxygenation post hypoxia-
targeted therapy,” Mol. Imaging Biol., vol. 17, no. 1, 2015. 
[15] D. Pilutti, M. Buchert, and S. Hadjidemetriou, “Registration of abdominal tumor 
DCE-MRI data based on deconvolution of joint statistics,” in Proceedings of the 
Annual International Conference of the IEEE Engineering in Medicine and 
Biology Society, EMBS, 2013, pp. 2611–2614. 
[16] L. S. Taylor et al., “Three-dimensional registration of prostate images from 
histology and ultrasound,” Ultrasound Med. Biol., vol. 30, no. 2, pp. 161–168, 
2004. 
[17] Y. Zhan, Y. Ou, M. Feldman, J. Tomaszeweski, C. Davatzikos, and D. Shen, 
“Registering Histologic and MR Images of Prostate for Image-based Cancer 
Detection,” Acad. Radiol., vol. 14, no. 11, pp. 1367–1381, 2007. 
[18] P. J. Slomka and R. P. Baum, “Multimodality image registration with software: 
state-of-the-art,” Eur. J. Nucl. Med. Mol. Imaging, vol. 36, no. 1, p. 44, 2008. 
[19] A. W. Toga and P. M. Thompson, “The role of image registration in brain 
mapping,” Image Vis. Comput., vol. 19, no. 1–2, pp. 3–24, 2001. 
32 
 
[20] C. Wang, J. J. Pahl, and R. E. Hogue, “A method for co-registering three-
dimensional multi-modality brain images.,” Comput. Methods Programs Biomed., 
vol. 44, no. 2, pp. 131–40, 1994. 
[21] P. J. Hoskin et al., “Hypoxia in Prostate Cancer: Correlation of BOLD-MRI With 
Pimonidazole Immunohistochemistry-Initial Observations,” Int. J. Radiat. Oncol. 
Biol. Phys., vol. 68, no. 4, pp. 1065–1071, 2007. 
[22] S. B. Donaldson et al., “Perfusion estimated with rapid dynamic contrast-enhanced 
magnetic resonance imaging correlates inversely with vascular endothelial growth 
factor expression and pimonidazole staining in head-and-neck cancer: A pilot 
study,” Int. J. Radiat. Oncol. Biol. Phys., vol. 81, no. 4, pp. 1176–1183, 2011. 
[23] L. Alic et al., “Facilitating tumor functional assessment by spatially relating 3D 
tumor histology and In Vivo MRI: Image registration approach,” PLoS One, vol. 6, 
no. 8, 2011. 
[24] M. Alegro et al., “Multimodal Whole Brain Registration: MRI and High 
Resolution Histology,” in IEEE Computer Society Conference on Computer Vision 
and Pattern Recognition Workshops, 2016, pp. 634–642. 
[25] D. Rueckert et al., “Nonrigid registration using free-form deformations: 
application to breast MR images.,” IEEE Trans. Med. Imag., vol. 18, no. 8, pp. 
712–21, 1999. 
[26] Z. Wang, A. C. Bovik, H. R. Sheikh, and E. P. Simoncelli, “Image quality 
assessment: From error visibility to structural similarity,” IEEE Trans. Image 
Process., vol. 13, no. 4, pp. 600–612, 2004. 
[27] L. Alic et al., “Multi-modal image registration : matching MRI with histology,” 
Imaging, vol. 7626, pp. 1–9, 2010. 
 
